SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
American Express disclosed third-quarter 2026 financial results on October 23, 2026, reporting net income of $3.7 billion, diluted EPS of $5.42 (up 31% YoY), and record Q3 revenue of $20.1 billion (up 9% YoY). The company also raised full-year 2026 EPS guidance to $18.30–$18.60. The earnings release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →Balchem Corporation disclosed quarterly financial results for Q3 2026 (ended September 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $290.7 million (up 8.6% YoY), net earnings of $46.7 million (up 16.0% YoY), adjusted EBITDA of $80.3 million (up 12.4% YoY), and diluted EPS of $1.46 (up from $1.24). This is a standard quarterly earnings release filed under Item 2.02, with comprehensive financial tables and segment performance details.
View raw filing on EDGAR →The disclosure centers on adoption of a new Lumen Executive Severance Plan and entry into participation agreements with named executive officers (including CEO Kate Johnson) that govern severance and change-of-control benefits. Although the filing states these changes "did not result in any material change to the severance or change in control benefits previously provided," the restructuring of compensatory arrangements—including the Restated Johnson Agreement specifying severance multiples (2.5x base plus target bonus upon CIC termination) and COBRA/outplacement terms—is a compensatory arrangement disclosure under Item 5.02(e). This is material to investors assessing executive retention and cost structure.
View raw filing on EDGAR →Sally J. Smith notified Hormel Foods of her decision to retire as a Board member, effective upon expiration of her current term at the 2027 Annual Meeting. The principal disclosed action is a director's departure through retirement, with explicit confirmation that she will not stand for re-election. This is a clear exec_departure event, material to investors as board composition changes affect governance and oversight.
View raw filing on EDGAR →S&P Global completed the separation of its Mobility segment into an independent public company (Mobility Global Inc.) on July 1, 2026, structured as a spin-off with pro rata distribution of shares to existing shareholders. This constitutes a material change of control and disposition event under Item 1.02/2.01 taxonomy, disclosed here under Item 8.01 with supporting pro forma financial statements showing the company's results as if the separation had occurred. The filing explicitly states this is a "previously announced separation" and "change of control" transaction that materially alters the registrant's business composition and financial profile.
View raw filing on EDGAR →Stacie Schulz, Chief Accounting Officer and principal accounting officer of Methode Electronics, resigned effective October 30, 2026, to pursue other opportunities. While the filing also discloses that Laura Kowalchik (CFO) will assume the additional responsibilities of principal accounting officer, the principal disclosed action centers on Schulz's departure from her officer role. The resignation of a principal accounting officer is material to investors as it affects the company's financial reporting oversight and internal controls.
View raw filing on EDGAR →Nordson Corporation completed its acquisition of Contrinex Holding SA for approximately $168 million USD on October 23, 2026, through its wholly-owned subsidiary Nordson London Limited. The acquisition adds a global sensor technology company with approximately $50 million in annual revenue and ~500 employees to Nordson's Advanced Technology Solutions segment, representing a material strategic expansion of the company's industrial sensing portfolio.
View raw filing on EDGAR →Gentex Corporation issued a news release on October 23, 2026 announcing financial results for the third quarter ended September 30, 2026, disclosing net sales of $647.7 million, gross margin of 33.4%, net income of $90.6 million (GAAP) and $97.8 million (non-GAAP), and earnings per diluted share of $0.43 (GAAP) and $0.47 (non-GAAP). The filing also includes updated full-year 2026 guidance and 2027 revenue outlook. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →This is Rogers Communications' third quarter 2026 earnings release, disclosing unaudited financial and operating results for the three and nine months ended September 30, 2026. The document presents consolidated financial highlights including total revenue ($5.4 billion, up 2%), adjusted EBITDA ($2.5 billion, up 1%), free cash flow ($1.4 billion, up 65%), and diluted EPS ($0.88, down 92% due to prior-year MLSE fair-value gain). The release includes segment results for Wireless, Cable, and Media, along with strategic highlights and management commentary from CEO Tony Staffieri. This is a material disclosure affecting investor assessment of the registrant's financial performance and operational execution.
View raw filing on EDGAR →The filing discloses the Board's declaration of cash dividends on two series of preferred stock: $0.453125 per share on the 7.25% Series B Cumulative Redeemable Preferred Stock and $0.40625 per share on the 6.50% Series C Cumulative Redeemable Preferred Stock, both payable November 20, 2026. This is a routine but material dividend distribution to preferred shareholders, clearly fitting the dividend_distribution category.
View raw filing on EDGAR →Paul C. Varga's resignation from the Board of Directors effective December 11, 2026, is the principal disclosed action. Although the filing also mentions Deirdre P. Connelly's appointment as Lead Independent Director, the core event centers on Varga's departure after 14 years of service, including his role as Lead Independent Director since 2021. The departure of a long-tenured lead independent director is material to investors' assessment of board governance and independence.
View raw filing on EDGAR →First Citizens BancShares disclosed third quarter 2026 earnings results on October 23, 2026, reporting net income of $606 million, adjusted net income of $652 million, and earnings per share of $51.23, along with comprehensive financial highlights including net interest income, noninterest income and expense, balance sheet metrics, credit quality, and capital ratios.
View raw filing on EDGAR →The Board authorized a $1.2 billion share repurchase program (the '2027 SRP') for Class A common stock in 2027, representing a discretionary capital return authorization that signals management's capital allocation priorities and confidence in valuation.
View raw filing on EDGAR →Sarah J. Zibbel, Executive Vice President and Chief Human Resources Officer, is departing the Company effective October 31, 2026, as her position is being eliminated in a human resources department restructuring. While the disclosure includes severance and equity treatment details, the principal disclosed action is the departure of a named executive officer. The materiality is supported by her senior officer status and the specific severance and equity arrangements disclosed.
View raw filing on EDGAR →Flagstar Bank, National Association issued a press release on October 23, 2026 reporting its third quarter 2026 financial results, including net income of $12 million ($0.01 per diluted share), net interest income of $460 million (up 5%), loan growth of $958 million, and provision for credit losses of $76 million. A written presentation was also distributed in connection with the earnings announcement.
View raw filing on EDGAR →Century Casinos received a deficiency notice from Nasdaq on October 19, 2026, for failing to maintain the minimum Market Value of Listed Securities (MVLS) of $35 million required under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days until April 19, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, with explicit language that "if the Company does not regain compliance by the Compliance Date, the Staff will provide written notification that the Company's common stock is subject to delisting."
View raw filing on EDGAR →The disclosure centers on a new employment agreement with Scott Macdonald, the existing CFO, detailing his compensation package including base salary ($1,060,000), annual bonus (125% target), equity awards (70% of base salary target), severance terms (18 months base salary), and change-of-control provisions. While the agreement also constitutes a continuation of his role, the substantive disclosure focuses on the compensatory arrangements and terms, making this a classic exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →The disclosure centers on an "enhanced compensation package" approved for Nicola Baty in connection with her appointment as President, effective October 21, 2026. The filing details specific compensatory arrangements: a $675,000 base salary, a 250% long-term equity incentive target, a grant of 58,245 restricted stock units vesting in 2029, and an 80% annual cash bonus target. While the appointment itself is mentioned, the substantive focus is on the compensation terms and equity grants, making this an exec_compensation event rather than exec_appointment.
View raw filing on EDGAR →Lord Abbett Private Credit Fund issued approximately 1.37 million common shares for $34.1 million ($24.86 per share) to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions from Securities Act registration.
View raw filing on EDGAR →The Company declared a distribution of approximately $0.22 per share to shareholders of record as of October 31, 2026, payable on or about November 24, 2026.
View raw filing on EDGAR →The Company disclosed portfolio composition and metrics as of September 30, 2026, including loan commitments of $2.364 billion, par value of $1.783 billion, weighted average yield of 9.6%, and industry diversification across 70 portfolio companies.
View raw filing on EDGAR →The Company issued approximately 169,368 common shares for $4.2 million to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions from Securities Act registration.
View raw filing on EDGAR →The Company declared a distribution of approximately $0.19 per share to shareholders of record as of October 31, 2026, payable on or about November 24, 2026.
View raw filing on EDGAR →GrafTech issued a press release on October 23, 2026 announcing unaudited financial results for the three and nine months ended September 30, 2026, including net sales, net loss, adjusted EBITDA, and cash flow metrics. This is a standard quarterly earnings disclosure furnished under Item 2.02 (Results of Operations and Financial Condition), with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →This is a shareholders' meeting summary disclosing the results of an Ordinary and Extraordinary General Shareholders' Meeting held on October 22, 2026. The document reports voting outcomes on 15 items including approval of financial results, dividend distribution (ARS 211 billion), board and supervisory committee appointments and compensation, auditor appointments, and approval of a material merger of two subsidiaries (Tienda Los Gallegos and Los Gallegos) into IRSA. The dividend distribution and merger approval are material events affecting shareholders' interests.
View raw filing on EDGAR →The filing discloses the Board of Directors' declaration of a quarterly cash dividend of $0.14 per share, with a record date of November 12, 2026 and payment date of December 3, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns policy.
View raw filing on EDGAR →The disclosure announces a Board-authorized stock repurchase plan for up to 5% of common stock (approximately 305,477 shares) to be executed over one year. Stock repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The authorization of a material repurchase program is material to investors as it signals capital allocation priorities and affects share count and earnings per share.
View raw filing on EDGAR →Matthew D. Mullet, who already serves as President and Chief Executive Officer of FS Bancorp and its subsidiary bank, has been appointed to the Boards of Directors of both entities effective October 22, 2026. This is a material governance event reflecting the elevation of an existing executive to board-level oversight responsibility. The disclosure emphasizes his extensive leadership experience and the Board's ratification of the appointment, making this a clear exec_appointment event.
View raw filing on EDGAR →Darden Restaurants entered into a $1.5 billion Amended and Restated Revolving Credit Agreement on October 22, 2026, replacing a prior $1.25 billion credit facility. The new senior unsecured credit commitment has a five-year maturity and will be used for working capital, capital expenditures, refinancing, and acquisitions.
View raw filing on EDGAR →This exhibit is the executed Business Combination Agreement dated 21 October 2026 between Crown NL Bidco B.V. (Buyer) and QIAGEN N.V. (Company) for a full public tender offer to acquire all issued ordinary shares of QIAGEN at EUR 46.50 per share. The agreement documents entry into a material acquisition transaction involving a change of control, with detailed provisions for the offer mechanics, financing, regulatory approvals, and post-closing restructuring including delisting and squeeze-out proceedings. This is a classic M&A activity disclosure under Item 1.01 of an 8-K equivalent.
View raw filing on EDGAR →This exhibit is a Phase 1 clinical trial presentation for IMA203CD8, Immatics' PRAME-directed TCR T-cell therapy, disclosing efficacy and safety results from a multicenter study (IMA203-101). The presentation reports a 51% objective response rate (ORR) across 90 evaluable patients with PRAME+ solid tumors, including gynecologic cancers, melanoma, and synovial sarcoma, with manageable tolerability and no dose-limiting maximum tolerated dose reached. This represents material clinical progress on a key pipeline asset that would affect investor assessment of the company's development trajectory and competitive position in cell therapy.
View raw filing on EDGAR →Eric Scheyer notified the Board on October 21, 2026 of his decision not to stand for re-election to the Board at the 2026 Annual Meeting, constituting a departure of a director. Although he will continue serving until the Annual Meeting, the principal disclosed action is his departure from the Board. The filing explicitly states his decision is not due to any disagreement with the Company, indicating an orderly transition rather than a contentious departure.
View raw filing on EDGAR →This is a TR-1 notification of major holdings disclosing that The Capital Group Companies, Inc. crossed a voting-rights threshold in British American Tobacco p.l.c., increasing its stake from 17.93% to 18.02% as of 21 October 2026. While the disclosure itself is a regulatory filing requirement under UK Disclosure Transparency Rules, the underlying event—a material change in significant shareholder position—would affect a reasonable investor's assessment of ownership and control dynamics. However, this does not fit neatly into the standard 8-K event taxonomy (no acquisition/disposal of the company itself, no executive change, no debt or capital event), making it a material event outside the defined categories.
View raw filing on EDGAR →Tompkins Financial Corporation issued a press release on October 23, 2026 announcing third-quarter 2026 earnings results, with diluted EPS of $2.00 (up 21.2% year-over-year) and net income of $28.7 million (up 21.0% YoY), reflecting strong operational performance.
View raw filing on EDGAR →The Board declared a quarterly dividend of $0.74 per share, payable November 13, 2026 to shareholders of record on November 6, 2026, representing a 13.8% increase compared to the prior year's fourth-quarter dividend.
View raw filing on EDGAR →The filing discloses the Board of Directors' declaration of a quarterly cash dividend of $0.06 per share payable on November 25, 2026. This is a routine but material capital allocation decision that affects shareholder value and is explicitly disclosed via press release. The filing notes this is the sixth consecutive quarterly dividend since reinstatement in July 2025 and the second at the increased $0.06 rate following a 20% increase approved in July 2026.
View raw filing on EDGAR →This 6-K furnishes a detailed summary of resolutions adopted at an Ordinary and Extraordinary General Shareholders' Meeting held on October 22, 2026. The document discloses voting results on fourteen items including approval of financial results (ARS 244.5 billion profit), dividend authorization (ARS 116 billion), board and supervisory committee appointments and compensation, auditor appointment, and other governance matters. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, reporting the outcomes of a shareholder meeting vote.
View raw filing on EDGAR →This exhibit is a notice announcing that Americas Gold and Silver will release third quarter 2026 results and host a conference call on November 13, 2026. Although the actual financial results are not yet disclosed in this document, the company explicitly states "Americas plans to issue a news release containing third quarter 2026 results before markets open in North America on Friday, November 13, 2026." This is a standard earnings announcement notice that precedes the release of quarterly financial results, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Apex Critical Metals Corp. entered into an underwriting agreement dated October 22, 2026 for a registered public offering of 2,400,000 common shares (400,000 ADSs) with an additional 360,000 shares (60,000 ADSs) available under an over-allotment option, led by underwriters including Maxim Group LLC.
View raw filing on EDGAR →HudBay Minerals completed and disclosed a Definitive Feasibility Study (DFS) for the Copper World Project in Arizona, including updated mineral reserve and resource estimates, mine design, capital and operating cost projections, and economic analysis. The DFS represents a material operational milestone affecting investor assessment of the project's economics, timeline, capital requirements, and the company's development pipeline.
View raw filing on EDGAR →Medicus Pharma received a delisting determination letter from Nasdaq on October 20, 2026, for failure to maintain the $1.00 minimum bid price requirement, but subsequently regained compliance on October 23, 2026. The company faces ongoing delisting risk and cannot assure future compliance with Nasdaq's continued listing standards.
View raw filing on EDGAR →Apex Critical Metals closed an underwritten public offering of 400,000 ADSs (representing 2.4 million common shares) at US$4.65 per ADS, generating gross proceeds of US$1.86 million pursuant to an effective Form F-10 shelf registration statement. The underwriter received a 45-day greenshoe option to purchase an additional 60,000 ADSs, and was granted representative warrants exercisable at US$5.81 per ADS through October 23, 2030, creating additional dilution potential for existing shareholders.
View raw filing on EDGAR →LKQ Corporation disclosed preliminary Q3 2026 financial results showing revenue of $3.32 billion (down from $3.50 billion YoY), a net loss of $16–32 million (versus $178 million net income in Q3 2025), and material impairment charges of $111 million. The company also withdrew full-year guidance.
View raw filing on EDGAR →Salvatore A. Abbate was appointed President and Chief Executive Officer of LKQ Corporation effective December 15, 2026, succeeding Justin L. Jude who resigned effective October 23, 2026. Abbate's compensation package includes a $1.34M base salary, $3.3M sign-on cash award, $12M sign-on RSUs, and $8M annual PSU target.
View raw filing on EDGAR →The 6-K body discloses announcement of quarterly and half-year financial results for the period ended September 30, 2026, with press releases attached under IFRS and Indian Accounting Standards. The filing also announces an interim dividend of 26/- per share and RSU grants to employees. The primary disclosure is the results announcement, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →The disclosure describes entry into a Purchase and Sale Agreement for the sale of real property (surplus seed property) for $5,900,000 to Washington County. While Item 1.01 typically covers M&A activity (acquisitions, mergers, dispositions), this is a straightforward asset sale of real property rather than a business acquisition or material disposition of a business line. The transaction is material in dollar terms ($5.9M) and would affect investor assessment of the company's capital and asset base, but does not constitute a change of control or business combination. This is classified as financial_other rather than ma_activity because it is a single-asset real estate sale rather than a material acquisition, disposition of a business, or change of control.
View raw filing on EDGAR →The filing discloses the completion of the sale of three business units (Personalization Mall, Things Remembered, and Personalization Universe) to PlanetArt, LLC for $45.0 million in cash on October 19, 2026. This represents a material disposition of assets that constitutes a strategic shift affecting the company's operations and financial results, as evidenced by the pro forma financial statements showing the divested businesses will be reported as discontinued operations and the company's use of proceeds to prepay term loan debt.
View raw filing on EDGAR →Cumberland announced top-line results from a Phase 2a clinical trial (ASSIST-SSc) for ifetroban in systemic sclerosis, demonstrating safety and tolerability. This is a material clinical milestone for a pharmaceutical company's drug development program, but does not fit the earnings_release category (which typically covers financial results) nor any other specific event type. The disclosure is clearly operational/strategic in nature—a significant development in the company's pipeline—making operational_other the most appropriate classification.
View raw filing on EDGAR →This exhibit is a press release announcing GasLog Partners LP's financial results for the three-month period ended September 30, 2026. It discloses quarterly revenues ($53.7 million), profit ($6.0 million), and condensed consolidated financial statements (balance sheet and income statement). The document is dated October 23, 2026, and explicitly states "GasLog Partners LP Reports Financial Results for the Three-Month Period Ended September 30, 2026," which is the hallmark of an earnings release. Material to investors as it reports quarterly operating performance and financial position.
View raw filing on EDGAR →This exhibit is a press release announcing the results of Amber International's annual general meeting held on October 23, 2026. Shareholders approved multiple resolutions including: (1) a one-off incentive share award of 23,469,189 Class B shares to Michael Wu; (2) appointment of Michael Wu as director and chairman; (3) appointments of four other directors (Jie Jiao, Vicky Wang, Yi Bao, Noorsurainah Tengah, Daniel-Philippe Mamadou-Blanco); and (4) amendments to the Post-IPO Share Incentive Plan with increased share reserve. These are classic shareholder vote results disclosures that would materially affect investor assessment of governance and capital structure.
View raw filing on EDGAR →